Entera Bio Ltd. announces 2026 shareholder meeting
- Scheduled for November 24, 2026
- Raised $275 million in private placement
- Proposals include equity grants for executives
ENTX
Entera Bio Ltd. SEC filings
Every EDGAR filing for Entera Bio Ltd. (ENTX), newest first, with AI summaries and stories.
- Ticker
- ENTX
- CIK
- 1638097
- Sector
- Biotech and pharma
- Latest filing
- 4d
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Filings
DEF 14AEntera Bio Ltd.ENTXLIVE 8-KEntera Bio Ltd.ENTXLIVE Entera Bio appoints Laura Hamill as director
- Laura Hamill appointed as Class I director effective Dec 1, 2026
- Yonatan Malca steps down as director effective Dec 1, 2026
- Ms. Hamill has 35+ years of biopharma commercial experience
PRE 14AEntera Bio Ltd.ENTXLIVE 424B3Entera Bio Ltd.ENTXLIVE S-3Entera Bio Ltd.ENTXLIVE 3Entera Bio Ltd.ENTXLIVE Riccardo Paolo Camisasca, new insider at ENTX
Riccardo Paolo Camisasca, reporting
8-KEntera Bio Ltd.ENTXLIVE DEntera Bio Ltd.ENTXLIVE 4Entera Bio Ltd.ENTXLIVE 9 insider filings
Yonatan Malca, insider filing for ENTX
Show all 9
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
Yonatan Malca, reporting
S-8Entera Bio Ltd.ENTXLIVE 10-QEntera Bio Ltd.ENTXLIVE 8-KEntera Bio Ltd.ENTXLIVE SCHEDULE 13GEntera Bio Ltd.ENTXLIVE Ownership stake disclosure by Longitude Capital Partners V, LLC
Longitude Capital Partners V, LLC, filed by
SCHEDULE 13GEntera Bio Ltd.ENTXLIVE Ownership stake disclosure by Seven Fleet Capital Management LP
Seven Fleet Capital Management LP, filed by
SCHEDULE 13DEntera Bio Ltd.ENTXLIVE Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND L P, filed by
SCHEDULE 13GEntera Bio Ltd.ENTXLIVE Ownership stake disclosure by TCG Crossover GP III, LLC
TCG Crossover GP III, LLC, filed by
SCHEDULE 13GEntera Bio Ltd.ENTXLIVE Ownership stake disclosure by Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity Fund Holdings, L.P., filed by
8-KEntera Bio Ltd.ENTXLIVE 8-KEntera Bio Ltd.ENTXLIVE 4Entera Bio Ltd.ENTXLIVE Miranda Jayne Toledano, insider filing for ENTX
Miranda Jayne Toledano, reporting
DEFA14AEntera Bio Ltd.ENTXLIVE ARSEntera Bio Ltd.ENTXLIVE DEF 14AEntera Bio Ltd.ENTXLIVE EFFECTEntera Bio Ltd.ENTXLIVE 424B3Entera Bio Ltd.ENTXLIVE PRE 14AEntera Bio Ltd.ENTXLIVE 4Entera Bio Ltd.ENTXLIVE 3 insider filings
Hillel Galitzer, insider filing for ENTX
Show all 3
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
Hillel Galitzer, reporting
S-3Entera Bio Ltd.ENTXLIVE 10-QEntera Bio Ltd.ENTXLIVE 8-KEntera Bio Ltd.ENTXLIVE 8-KEntera Bio Ltd.ENTXLIVE 10-KEntera Bio Ltd.ENTXLIVE 8-KEntera Bio Ltd.ENTXLIVE 4Entera Bio Ltd.ENTXLIVE Geno J Germano, insider filing for ENTX
Geno J Germano, reporting
4Entera Bio Ltd.ENTXLIVE Sean Ellis, insider filing for ENTX
Sean Ellis, reporting
8-KEntera Bio Ltd.ENTXLIVE 4Entera Bio Ltd.ENTXLIVE Steven D Rubin, insider filing for ENTX
Steven D Rubin, reporting
4Entera Bio Ltd.ENTXLIVE 3 insider filings
Haya Taitel, insider filing for ENTX
Show all 3
- 4Insider filing for ENTX
- 4Insider filing for ENTX
- 4Insider filing for ENTX
Haya Taitel, reporting